In Vitro Susceptibility of HIV Isolates with High Growth Capability to Antiretroviral Drugs

In Vitro Susceptibility of HIV Isolates with High Growth Capability to Antiretroviral Drugs

It has been considered that reduced susceptibility to antiretroviral drugs is influenced by drug adherence, drug tolerance and drug-resistance-related mutations in the HIV genome. In the present study, we assessed the intrinsic high viral growth capability as a potential viral factor that may influe...

Full description

Bibliographic Details
Main Authors:	Alfredo A. Hinay, Kyosuke Kanai, Akeno Tsuneki-Tokunaga, Mizuki Komatsu, Elizabeth O. Telan, Seiji Kageyama
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	International Journal of Molecular Sciences
Subjects:	human immunodeficiency virus antiretroviral drugs viral growth capability
Online Access:	https://www.mdpi.com/1422-0067/23/23/15380

Similar Items

Pro-Inflammatory Cytokines and Interferon-Stimulated Gene Responses Induced by Seasonal Influenza A Virus with Varying Growth Capabilities in Human Lung Epithelial Cell Lines
by: Alfredo A. Hinay, et al.
Published: (2022-09-01)

Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines
by: Seiji Kageyama MD, Phd, et al.
Published: (2019-06-01)

Osteoarticular complications related to HIV infection and highly active antiretroviral therapy
by: Ana Lúcia Lei Munhoz Lima, et al.

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
by: Matthew Pace, et al.
Published: (2022-08-01)

Proportion and determinants of adherence to antiretroviral therapy among HIV positive people registered under ART center in South India
by: Vandana Hiregoudar, et al.
Published: (2019-01-01)

Virologic response to antiretroviral therapy among human immunodeficiency virus-infected adults in a tertiary healthcare facility in Enugu State Nigeria
by: Izuchukwu F Obi, et al.
Published: (2022-01-01)

Quantification and factors associated with HIV-related stigma among persons living with HIV/AIDS on antiretroviral therapy at the HIV-day care unit of the Bamenda Regional Hospital, North West Region of Cameroon
by: Atem Bethel Ajong, et al.
Published: (2018-06-01)

"CLINICAL OUTCOME OF HIV INFECTED PATIENTS ACCORDING TO IMMUNOLOGIC RESPONSE AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY "
by: M. Rasoolinejad, et al.
Published: (2005-02-01)

"CLINICAL OUTCOME OF HIV INFECTED PATIENTS ACCORDING TO IMMUNOLOGIC RESPONSE AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY "
by: M. Rasoolinejad, et al.
Published: (2005-04-01)

ADHERENCE TO ANTIRETROVIRAL THERAPY FOR HIV/AIDS
by: Stela Maris de Mello Padoin, et al.
Published: (2013-09-01)

Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
by: F.R. Machado, et al.
Published: (2006-01-01)

HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy
by: Steven A. Kemp, et al.
Published: (2022-06-01)

Effectiveness of antiretroviral therapy (haart) In hiv positive patients admitted to the treatment Program of “atencion integral ips” in the city of Cartagena. Colombia
by: Torres-Mora Gustavo, et al.
Published: (2011-06-01)

Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data
by: Ashley O. Otto, et al.
Published: (2021-05-01)

Survival and prognostic factors of HIV-positive patients after antiretroviral therapy initiation at a Malaysian referral hospital
by: Lee Sing Chet, et al.
Published: (2021-01-01)

CD4 LYMPHOCYTE IN HIV / AIDS BEFORE AND AFTER ANTIRETROVIRAL THERAPY
by: Rangsang Bagus Prabowo, et al.
Published: (2017-10-01)

Cost-Effectiveness of antiretroviral therapy: A systematic review
by: Indrani Gupta, et al.
Published: (2020-01-01)

The Adherence to Fixed-Dose Combination Antiretroviral Therapy and Viral Load in HIV Patients
by: Salma Auliannissa, et al.
Published: (2020-01-01)

FAMILY CARE IN COMPLIANCE WITH ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV/AIDS
by: Tassiana Potrich, et al.
Published: (2013-06-01)

Determinants of discordant immune response in a cohort of human immunodeficiency virus-infected patients initiating antiretroviral therapy
by: Abdullahi Umar, et al.
Published: (2020-01-01)

Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco
by: Titou Hicham, et al.
Published: (2019-01-01)

Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia
by: Anteneh Amsalu, et al.
Published: (2017-05-01)

A mixed method assessment of the fertility preferences of clients using antiretroviral therapy in Ilorin, Nigeria – A descriptive cross-sectional survey
by: Adedayo Ayodele Aderibigbe, et al.
Published: (2024-01-01)

Analysis of the frequency of formation of HIV mutations associated with resistance to antiretroviral drugs
by: M.G. Liulchuk, et al.
Published: (2020-09-01)

Adverse Drug Reactions to Antiretroviral Therapy in Federal Medical Centre, Makurdi, Nigeria
by: Elias Adikwu, et al.
Published: (2022-11-01)

HIV antiretroviral preexposure prophylaxis
by: Richard Tjan
Published: (2015-12-01)

Studying the Causes of Virologic Failure in the Early Stages of Antiretroviral Therapy in HIV-Infected Patients
by: M.H. Liulchuk
Published: (2015-02-01)

Longitudinal comparison between plasma and seminal HIV-1 viral loads during antiretroviral treatment Comparação longitudinal entre cargas virais seminais e plasmáticas do HIV-1 durante terapia anti-retroviral
by: Lauro Ferreira da Silva Pinto Neto, et al.
Published: (2003-12-01)

Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment
by: Wendy Grant-McAuley, et al.
Published: (2022-11-01)

Effects of Efavirenz for the Treatment of HIV on the Basis of Genetic Polymorphisms
by: Brighty Elizabeth Kurian, et al.
Published: (2022-04-01)

Analysis of compliance to antiretroviral treatment among patients with HIV/AIDS
by: Hélia Carla de Souza, et al.

Effect of anthropometric and sociodemographic variables on physical activity levels of people living with human immunodeficiency virus/acquired immunodeficiency syndrome on highly active antiretroviral therapy
by: Jane Nwanneka Anikpe, et al.
Published: (2023-01-01)

Investigating bothersome lower urinary tract symptoms among people living with HIV on antiretroviral therapy: prevalence, influencing factors, and quality-of-life implications
by: Imane H. S. Benyamina, et al.
Published: (2023-11-01)

Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States
by: Kunchok Dorjee, et al.
Published: (2021-09-01)

Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia
by: María Fernanda Álvarez Barreneche, et al.
Published: (2017-11-01)

High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal
by: Abdoul-Magib Cissé, et al.
Published: (2019-02-01)

Antiretroviral Drug Discovery Targeting the HIV-1 Nef Virulence Factor
by: Lori A. Emert-Sedlak, et al.
Published: (2022-09-01)

Current antiretroviral drugs for human immunodeficiency virus infection: review article
by: Ahmad Tavakoli, et al.
Published: (2019-08-01)

Virologic failure in HIV-positive adolescents with perfect adherence in Uganda: a cross-sectional study
by: Julian Natukunda, et al.
Published: (2019-01-01)

Liver function in children with human immunodeficiency virus infection before and after 6 months of highly active antiretroviral therapy
by: Eva Jacomina Jemima Sapulete, et al.
Published: (2018-07-01)